These findings lead us to the hypothesis that pivotal immunopathogenic disease drivers in SLE, such as IFN-α, and the overall SLE inflammatory activity may drive the accelerated neuronal damage observed in SLE patients, with or without NPSLE, ultimately leading to MRI alterations and cognitive dysfunction. Here, IFNA1 is linked to systemic lupus erythematosus.